Application no. and date | 06839331.3 (espacenet) (Federated) (European Patent Register), 20061212 | Patent/reg. no. and date | DK/EP 1965768, 20090513 | Publication date | 20080910 | Priority no. and date | US 750303 P, 20051214 | EP pub. no. and date |
EP 1965768 20080910 | Effective date | | Applicant/owner | Sanofi-Aventis U.S. LLC, 55 Corporate Drive
Bridgewater, NJ 08807, US | Applicant ref. no. | AVENT US 2005/158 | Inventor | AGRAWALA, Prafulla, 95 Eleanor Drive
Kendall Park, New Jersey 08824, US, CHRZAN, Kazimierz, 206 Creekside Drive
New Hope, Pennsylvania 18938, US, HARIBHAKTI, Rajiv, 90 Addis Drive
Churchville, Pennsylvania 18966, US, MERMEY, Matthew, 14601 Mohawk Lane
Leawood, Kansas 66224, US, PORCELLO, Curtis, J., 5 Locke Court
Ewing, New Jersey 08628, US, SILVEY, Gary, Lee, 10139 Switzer Drive
Overland Park, K 66212, US, TRAN, Vinh, 2752 W. 131st Terrace
Leawood, Kansas 66209, US | Representative | | Opponent | | IPC Class | A61K 31/445 (2006.01) , A61K 9/16 (2006.01) | Title | Fexofenadin-opløsningsformulering | Int. application no. | US2006047393 | Int. publication no. | WO2007070517 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|